HIGH RISK PERCUTANEOUS CORONARY INTERVENTION
Clinical trials for HIGH RISK PERCUTANEOUS CORONARY INTERVENTION explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK PERCUTANEOUS CORONARY INTERVENTION trials appear
Sign up with your email to follow new studies for HIGH RISK PERCUTANEOUS CORONARY INTERVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart pump aims to make risky artery procedures safer
Disease control OngoingThis study tests a temporary heart pump called Impella ECP in 100 adults undergoing high-risk angioplasty. The pump helps maintain blood flow during the procedure. Researchers are checking if the device is safe and works as intended, with follow-up for 30 days after the procedure…
Matched conditions: HIGH RISK PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New heart pump aims to make risky artery procedures safer
Disease control ENROLLING_BY_INVITATIONThis study tests the Impella ECP, a temporary heart pump, in 856 adults undergoing high-risk angioplasty (a procedure to open blocked heart arteries). The pump is inserted before the procedure to help keep blood flowing. Researchers will track major heart and brain complications,…
Matched conditions: HIGH RISK PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC